Initial Prior Authorization with Quantity Limit Voltaren Gel
Customize your policy alerts
Sign up for cvs_caremark Policy 475-C alerts
Get alerted when Policy 475-C changes without checking for updates manually.
Monitor payer policy activity
This policy governs initial and continuation prior authorization, including quantity limits, for diclofenac sodium topical gel 1% and Voltaren Gel OTC. Coverage applies to osteoarthritis pain in joints amenable to topical treatment when specified clinical criteria are met.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.